Cargando…

Vitamin D status and associations with substance use patterns among people with severe substance use disorders in Western Norway

Chronic and harmful substance use is associated with a cluster of harms to health, including micronutrient deficiencies. Maintaining adequate levels of vitamin D is important for musculoskeletal and other aspects of health. In this prospective longitudinal cohort study, 666 participants drawn from o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Bemanian, Mitra, Chowdhury, Ranadip, Stokke, Krister, Aas, Christer Frode, Johansson, Kjell Arne, Vold, Jørn Henrik, Fadnes, Lars Thore
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9372185/ https://www.ncbi.nlm.nih.gov/pubmed/35953499 http://dx.doi.org/10.1038/s41598-022-17804-w

Ejemplares similares

Vitamin B12 Levels, Substance Use Patterns and Clinical Characteristics among People with Severe Substance Use Disorders: A Cohort Study from Western Norway
por: Madebo, Tesfaye, et al.
Publicado: (2022)

Folate Status as a Nutritional Indicator among People with Substance Use Disorder; A Prospective Cohort Study in Norway
por: Bemanian, Mitra, et al.
Publicado: (2022)

Substance use and symptoms of mental health disorders: a prospective cohort of patients with severe substance use disorders in Norway
por: Aas, Christer Frode, et al.
Publicado: (2021)

Validation of a three-item Fatigue Severity Scale for patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Changes in substance use during outpatient treatment for substance use disorders: a prospective Norwegian cohort study from 2016 to 2020
por: Vold, Jørn Henrik, et al.
Publicado: (2021)

Impact of clinical and sociodemographic factors on fatigue among patients with substance use disorder: a cohort study from Norway for the period 2016–2020
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Too much or too little opioids to patients receiving opioid agonist therapy in Norway (2013–2017): a prospective cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Integrated care of severe infectious diseases to people with substance use disorders; a systematic review
por: Vold, Jørn Henrik, et al.
Publicado: (2019)

Dispensations of benzodiazepines, z-hypnotics, and gabapentinoids to patients receiving opioid agonist therapy; a prospective cohort study in Norway from 2013 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Prevalence and correlates of suicide attempts in high-risk populations: a cross-sectional study among patients receiving opioid agonist therapy in Norway
por: Vold, Jørn Henrik, et al.
Publicado: (2022)

Dispensation of attention deficit hyperactivity disorder (ADHD) medications in patients receiving opioid agonist therapy; a national prospective cohort study in Norway from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Health-related quality of life of long-term patients receiving opioid agonist therapy: a nested prospective cohort study in Norway
por: Aas, Christer Frode, et al.
Publicado: (2020)

Potentially addictive drugs dispensing to patients receiving opioid agonist therapy: a register-based prospective cohort study in Norway and Sweden from 2015 to 2017
por: Vold, Jørn Henrik, et al.
Publicado: (2020)

Uptake and predictors of direct-acting antiviral treatment for hepatitis C among people receiving opioid agonist therapy in Sweden and Norway: a drug utilization study from 2014 to 2017
por: Aas, Christer F., et al.
Publicado: (2020)

Subjective symptoms and serum methadone concentrations: what should guide dose adjustments in methadone maintenance treatment? A naturalistic cohort study from Norway
por: Chalabianloo, Fatemeh, et al.
Publicado: (2021)

Attention-deficit/hyperactivity disorder (ADHD) symptoms and their relation to diagnosed ADHD, sociodemographic characteristics, and substance use among patients receiving opioid agonist therapy: a Norwegian cohort study
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

On the path towards universal coverage of hepatitis C treatment among people receiving opioid agonist therapy (OAT) in Norway: a prospective cohort study from 2013 to 2017
por: Aas, Christer Frode, et al.
Publicado: (2020)

The efficacy of integrated hepatitis C virus treatment in relieving fatigue in people who inject drugs: a randomized controlled trial
por: Vold, Jørn Henrik, et al.
Publicado: (2023)

Emotional Eating and Changes in High-Sugar Food and Drink Consumption Linked to Psychological Distress and Worries: A Cohort Study from Norway
por: Javadi Arjmand, Elaheh, et al.
Publicado: (2023)

Peer involvement and cross-sector efforts in establishing integrated treatment of hepatitis C virus infection for people with substance use disorders: experiences from Norway
por: Lygren, Ole Jørgen, et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: study protocol for a randomised controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2019)

Integrated treatment of hepatitis C virus infection among people who inject drugs: A multicenter randomized controlled trial (INTRO-HCV)
por: Fadnes, Lars T., et al.
Publicado: (2021)

Emotional Eating in Relation to Worries and Psychological Distress Amid the COVID-19 Pandemic: A Population-Based Survey on Adults in Norway
por: Bemanian, Mitra, et al.
Publicado: (2020)

Oral health related quality of life and reasons for non‐dental attendance among patients with substance use disorders in withdrawal rehabilitation
por: Åstrøm, Anne Nordrehaug, et al.
Publicado: (2021)

Effect of fruit smoothie supplementation on psychological distress among people with substance use disorders receiving opioid agonist therapy: protocol for a randomised controlled trial (FruktBAR)
por: Fadnes, Lars T., et al.
Publicado: (2022)

Perfluoroalkyl Substances in the Western Tropical Atlantic Ocean
por: Miranda, Daniele de A., et al.
Publicado: (2021)

Substance use problems among people with mild/borderline intellectual disability: Challenges to mainstream multidisciplinary specialist substance treatment in Norway
por: Juberg, Anne, et al.
Publicado: (2017)

Governance of substance use as a by-product of policing in Norway: A historical account
por: Johansen, Kenneth Arctander, et al.
Publicado: (2018)

Effects of Nutritional Interventions in Individuals with Chronic Obstructive Lung Disease: A Systematic Review of Randomized Controlled Trials
por: Furulund, Einar, et al.
Publicado: (2021)

Substance use among inmates at the Eldoret prison in Western Kenya
por: Kinyanjui, Daniel WC, et al.
Publicado: (2013)

Associations between psychoactive substance use and sensation seeking behavior among drivers in Norway
por: Jamt, Ragnhild E. G., et al.
Publicado: (2020)

Integration of smoking cessation into standard treatment for patients receiving opioid agonist therapy who are smoking tobacco: protocol for a randomised controlled trial (ATLAS4LAR)
por: Druckrey-Fiskaaen, Karl Trygve, et al.
Publicado: (2022)

Changes in Body Mass Index and Their Associations with Psychological Distress, Worries, and Emotional Eating during the COVID-19 Pandemic: A Norwegian Cohort Study
por: Arjmand, Elaheh Javadi, et al.
Publicado: (2023)

Mobile Assessments of Mood, Cognition, Smartphone-Based Sensor Activity, and Variability in Craving and Substance Use in Patients With Substance Use Disorders in Norway: Prospective Observational Feasibility Study
por: Lauvsnes, Anders Dahlen Forsmo, et al.
Publicado: (2023)

Assessing health service satisfaction among users with substance use disorders within the municipalities in Norway
por: Stallvik, Marianne, et al.
Publicado: (2019)

Prevalence of substance use among college students in Eldoret, western Kenya
por: Atwoli, Lukoye, et al.
Publicado: (2011)

Patients admitted to treatment for substance use disorder in Norway: a population-based case–control study of socio-demographic correlates and comparative analyses across substance use disorders
por: Amundsen, Ellen J., et al.
Publicado: (2022)

Consumption of Nuts and Seeds and Health Outcomes Including Cardiovascular Disease, Diabetes and Metabolic Disease, Cancer, and Mortality: An Umbrella Review
por: Balakrishna, Rajiv, et al.
Publicado: (2022)

Substance use risk profiles and associations with early substance use in adolescence
por: Malmberg, Monique, et al.
Publicado: (2010)

Substance use disorders: diagnosis and management for hospitalists
por: Pasha, Ahmed K., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_a8o79o4sa5urco9qvdo8r4kr30